Steven A. Rosenberg, MD, PhD, FAACR, will receive this year’s Pezcoller Foundation-American Association of Cancer Research International Award for Extraordinary Achievement in Cancer Research.
The award recognizes a scientist who has made a major scientific discovery in basic or translational cancer research, remains active in cancer research, and is conducting ongoing work that offers promise for continued substantive contributions to progress in cancer.
Rosenberg will be honored for his discovery and development of interleukin-2 — the first FDA-approved immunotherapy for people